Early adverse outcomes remain challenging to prevent in morbidly obese patients undergoing total hip arthroplasty.

Autor: Dugdale EM; Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA., Uvodich ME; Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA., Pagnano MW; Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA., Berry DJ; Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA., Abdel MP; Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA., Bedard NA; Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Jazyk: angličtina
Zdroj: The bone & joint journal [Bone Joint J] 2024 Nov 01; Vol. 106-B (11), pp. 1223-1230. Date of Electronic Publication: 2024 Nov 01.
DOI: 10.1302/0301-620X.106B11.BJJ-2023-1187.R1
Abstrakt: Aims: The prevalence of obesity is increasing substantially around the world. Elevated BMI increases the risk of complications following total hip arthroplasty (THA). We sought to evaluate trends in BMI and complication rates of obese patients undergoing primary THA over the last 30 years.
Methods: Through our institutional total joint registry, we identified 15,455 primary THAs performed for osteoarthritis from 1990 to 2019. Patients were categorized according to the World Health Organization (WHO) obesity classification and groups were trended over time. Cox proportional hazards regression analysis controlling for confounders was used to investigate the association between year of surgery and two-year risk of any reoperation, any revision, dislocation, periprosthetic joint infection (PJI), venous thromboembolism (VTE), and periprosthetic fracture. Regression was stratified by three separate groups: non-obese; WHO Class I and Class II (BMI 30 to 39 kg/m 2 ); and WHO Class III patients (BMI ≥ 40 kg/m 2 ).
Results: There was a significant increase in the proportion of all obesity classes from 1990 to 2019, and the BMI values within each WHO class significantly increased over time. Risk of any reoperation did not change over time among non-obese or WHO Class I/II patients, but increased for WHO Class III patients (hazard ratio (HR) 1.04; p = 0.044). Risk of dislocation decreased over time for non-obese (HR 0.96; p < 0.001) and WHO Class I/II (HR 0.96; p = 0.002) patients, but did not change over time for WHO Class III (HR 0.94; p = 0.073) patients. Risks of any revision and PJI did not change over time for any group.
Conclusion: The proportion of patients undergoing THA who are obese has increased dramatically at our institution between 1990 and 2019. Despite BMI values increasing within all WHO classes over time, two-year complication risks have remained stable or decreased in WHO Class I/II patients. However, continued efforts will be required to mitigate risks in the heaviest WHO Class III patients.
Competing Interests: The authors received no financial or material support for the research, authorship, and/or publication of this article.
(© 2024 The British Editorial Society of Bone & Joint Surgery.)
Databáze: MEDLINE